Related Experiment Video
Updated: Jun 21, 2025

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
Published on: March 25, 2020
Glycodeoxycholic acid as alternative treatment in 3β-hydroxy-Δ5-C27-steroid-oxidoreductase: a case report
S Majait1, F M Vaz2,3,4, E Marleen Kemper5
1Department of Pharmacy and Clinical Pharmacology, Amsterdam UMC Location University of Amsterdam, Amsterdam, Netherlands.
Background:
3β-hydroxy-Δ5-C27-steroid-oxidoreductase (3β-HSD) deficiency is a bile acid synthesis disorder that leads to the absence of normal primary bile acids and the accumulation of abnormal bile acids. This results in cholestatic jaundice, fat-soluble vitamin deficiency, acholic or fatty stools and failure to thrive. Bile acid supplementation is used to treat 3β-HSD-deficiency and its symptoms.
Methods:
This report details the case of a 28-year-old woman diagnosed with 3β-HSD-deficiency, who was treated with glycine-conjugated deoxycholic acid (gDCA).
Results:
gDCA treatment successfully restored normal bile acid levels, improved body weight by reducing fat malabsorption, and was well-tolerated with no observed liver problems or side effects.
Conclusions:
As a potent FXR ligand, gDCA might exert its action through FXR activation leading to bile acid synthesis regulation.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Drugs for Treatment of Ulcerative Colitis in IBD
Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids

